North and South Pavilion works completed
We are excited to share that the redevelopment works of the North Pavilion and South Pavilion of the Human Technopole campus have been completed.
The buildings, originally built for Expo Milano 2015 to accommodate exhibition space and restaurants will now host laboratory and office space as well as state-of-the-art facilities for life science research.
The North Pavilion works were completed in mid-March 2021. The ground floor of the pavilion will host HT’s Cryo-EM Facility and Light Microscopy Facility equipped with latest technologies. The first floor of the building will host an open space office setting with worksations for microscopy image analysis. The building has been adapted to meet the technical requirements of the microscopes, for example by managing the environmental conditions of the rooms and inserting special platforms to avoid vibrations and support the machines’ weight.
The South Pavilion works were completed in mid-April 2021. The full redevelopment of the building meets the engineering and testing needs of the laboratories and is in line with energy efficiency requirements. It will host lab spaces for Neurogenomics and Genomics and research activities as well as part of HT’s core facilities. It will have feature 60 and 90 workstations (depending on the final layout) and will link to Palazzo Italia, Human Technopole’s institutional headquarters, through a suspended tunnel.
Both buildings will now be furnished and set up to welcome Human Technopole researchers in the coming months.
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.